No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Par Drugs and Chemicals Limited is an Indian enterprise that focuses on the creation, production, and sale of active pharmaceutical ingredients (APIs) and specialized chemicals. Its comprehensive product line features a diverse array of compounds, such as magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, as well as various amorphous and custom-blended formulations. The company also extends its market presence through international exports. Founded in 1982, Par Drugs and Chemicals Limited is headquartered in Vadodara, India.
pardrugs.comNo one on the platform currently holds PAR.NS.
No tracked institution reports a position in PAR.NS as of their last filing.
No one on the platform has traded PAR.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PAR.NSPar Drugs and Chemicals Limited | $127.19 | -5.00% | $1.6B | — |
| ACHYUT.BOAchyut Healthcare Ltd. | $6.89 | +1.03% | $1.7B | — |
| BALPHARMA.BOBal Pharma Limited | $101.92 | -5.07% | $1.6B | — |
| BALPHARMA.NSBal Pharma Limited | $102.00 | -5.06% | $1.6B | — |
| DENISCHEM.BODenis Chem Lab Limited | $70.00 | -0.65% | $971M | — |
| KREBSBIO.BOKrebs Biochemicals & Industries Limited | $56.05 | -1.08% | $1.2B | — |
| KREBSBIO.NSKrebs Biochemicals & Industries Limited | $56.36 | +0.16% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry